Related Experiment Video
Updated: Jul 16, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Advances in prostate cancer immunotherapies
Michael Basler1, Marcus Groettrup
1Division of Immunology, Department of Biology, University of Constance, Konstanz, Germany. Michael.Basler@uni-konstanz.de
Drugs & Aging
|March 17, 2007
Summary
Developing novel immunotherapies is crucial for hormone-refractory prostate cancer. Current treatments offer limited survival benefits, highlighting the need for better prostate cancer therapies.
Area of Science:
- Oncology
- Immunology
- Urology
Background:
- Prostate cancer is a leading cause of cancer mortality in men.
- Current treatments for early-stage prostate cancer are effective, but hormone-refractory disease has limited therapeutic options.
- Aggressive chemotherapies offer only marginal survival benefits for advanced prostate cancer.
Purpose of the Study:
- To review the current landscape of immunotherapy strategies for hormone-refractory prostate cancer.
- To evaluate the efficacy and safety of various immunotherapeutic approaches.
- To identify promising avenues for future prostate cancer treatment development.
Main Methods:
- Review of clinical trials and studies on prostate cancer immunotherapy.
- Analysis of treatments including antibody therapy, whole-cell based vaccines, viral vector vaccines, and dendritic cell vaccines.
- Evaluation of specific immunotherapy products like Sipuleucel-T.
Main Results:
- Antibody therapies targeting HER2 and PSMA showed PSA stabilization in some patients.
- Whole-cell vaccines and viral vector vaccines (poxvirus, adenovirus) demonstrated safety and PSA stabilization.
- Dendritic cell vaccination elicited cytotoxic T-cell responses.
- Sipuleucel-T improved median time to disease progression and overall survival by 4.5 months.
Conclusions:
- Immunotherapy offers a promising strategy for hormone-refractory prostate cancer.
- While some immunotherapies show modest survival benefits, more effective treatments are needed.
- Prostate cancer's non-essential organ status makes it a suitable target for immunotherapy development.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...